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L-lactate is a product of aerobic glycolysis that can be used by
neurons as an energy substrate. Here we report that in neurons
L-lactate stimulates the expression of synaptic plasticity-related
genes such as Arc, c-Fos, and Zif268 through a mechanism involv-
ing NMDA receptor activity and its downstream signaling cascade
Erk1/2. L-lactate potentiates NMDA receptor-mediated currents
and the ensuing increase in intracellular calcium. In parallel to this,
L-lactate increases intracellular levels of NADH, thereby modulat-
ing the redox state of neurons. NADH mimics all of the effects of
L-lactate onNMDA signaling, pointing to NADH increase as a primary
mediator of L-lactate effects. The induction of plasticity genes is
observed both in mouse primary neurons in culture and in vivo
in the mouse sensory-motor cortex. These results provide insights
for the understanding of the molecular mechanisms underlying
the critical role of astrocyte-derived L-lactate in long-term memory
and long-term potentiation in vivo. This set of data reveals a pre-
viously unidentified action of L-lactate as a signaling molecule for
neuronal plasticity.
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The transfer of L-lactate from astrocytes to neurons was re-cently shown to be necessary for the establishment of long-
term memory (LTM) in an inhibitory avoidance (IA) paradigm
and for the maintenance of in vivo long-term potentiation (LTP)
in the rodent hippocampus (1). This key role of L-lactate in
neuronal plasticity mechanisms was demonstrated in experi-
ments in which specific pharmacological and gene expression
down-regulation interventions were implemented to prevent the
production of L-lactate from glycogen—which is exclusively lo-
calized in astrocytes—and its release from these cells in the
hippocampus during behavioral training (1). Such interventions
completely prevented the establishment of LTM and their effect
was fully reversed by the intrahippocampal administration of
L-lactate during the training session. The fact that glucose at
equicaloric concentrations only marginally mimicked the rescu-
ing effect of L-lactate was taken as an unexpected indication that
the primary mechanism of action of L-lactate on plasticity
mechanisms was independent of its ability to act as an energy
substrate. A role of L-lactate in memory processes was also re-
cently shown in other behavioral paradigms (2, 3). We therefore
set out to investigate the molecular mechanisms at the basis of
the function of L-lactate on neuronal plasticity.
Molecular mechanisms underlying both LTM and long-term
plasticity include the induction of expression of a group of im-
mediate early genes (IEGs) such as early growth response 1
(Zif268 or Egr1), CCAAT/enhancer binding protein (C/EBP),
and proto-oncogene c-Fos (c-Fos) as well as activity-regulated
cytoskeletal-associated protein (Arc or Arg3.1) as a direct
effector protein at the synapse, which all participate to different
physiological processes associated with neuronal plasticity
(4–6). Although stimulation of expression of these IEGs is not
restricted to plasticity processes, they are considered as key
plasticity-related genes in sustaining such phenomena. In addi-
tion, late response genes such as brain-derived neurotrophic
factor (BDNF) have also been demonstrated to be major
intermediates of plasticity-related processes (7). A role of
NMDA receptors (NMDARs) in such plasticity mechanisms is
well-established (5, 8).
In this article we describe a cascade of molecular events
demonstrating that L-lactate stimulates plasticity-related gene
expression in neurons through modulation of NMDAR activity
associated with changes in redox cellular state. The induction
of plasticity gene expression by L-lactate was observed in primary
cultures of neurons as well as in vivo in the sensory-motor
cortex of mice.
Results
L-Lactate Induces the Expression of Plasticity Genes. L-lactate applied
to primary neuronal cultures of the mouse neocortex stimulated
Arc expression in a concentration- and time-dependent manner
(Fig. 1 A and B). Significant effects started to be observed at
2.5 mM (48.2 ± 12.1% increase compared with control values),
increased up to 20 mM, and are maximally expressed after 1 h of
treatment. L-lactate induced the expression of two other synaptic
plasticity-related IEGs, c-Fos and Zif268 (4–6) (Fig. 1B). The effect
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of L-lactate on expression of IEGs was specific; D-lactate (non-
metabolized enantiomer), L-pyruvate (another monocarboxylate),
and D-glucose (used at a similar or equicaloric concentration to
20 mM L-lactate) were inactive under identical experimental
conditions (Fig. 1C). Increased IEG mRNA expression levels
induced by L-lactate were correlated with the protein levels as
shown by Western blot experiments (Fig. 1D), with maximum
values being observed after 1 h of treatment (fold increase: 4.0,
5.5, and 3.2 vs. control values for Arc, c-Fos, and Zif268, re-
spectively; Fig. 1E). To assess the importance of intracellular
L-lactate transport on IEG mRNA expression, the mono-
carboxylate transporters (MCTs) inhibitor UK5099 was used.
As shown in Fig. 1F, the stimulatory effects of L-lactate on IEG
mRNA expression was fully prevented in the presence of 50 μM
UK5099. In addition to IEGs, expression levels of BDNF, a key
mediator of late-phase synaptic plasticity processes (7), was also
significantly induced by 20 mM L-lactate at later time points, with
maximum values obtained at 4 h (351.0 ± 58.9% of increase
compared with control values; mean ± SEM; n = 9, three in-
dependent experiments; Student t test: P ≤ 0.001). In contrast to
Arc, c-Fos and Zif268 mRNA expression the IEG C/EBPγ iso-
form, that has been shown to participate in synaptic plasticity
and memory formation processes (4) was not modulated by
L-lactate (20 mM) after 1 h of treatment (100.0 ± 2.4% com-
pared with control values; mean ± SEM; n = 6, two independent
experiments, P > 0.05 by Student t test).
L-Lactate Potentiates NMDAR Signaling. NMDARs are ionotropic
glutamate receptors that are prototypical mediators of synaptic
plasticity processes involving the induction of plasticity-related
genes such as Arc and Zif268 (5, 8). We therefore considered the
possibility that NMDARs could be potential candidates as
mediators of the effects of L-lactate on IEG expression. Con-
sistent with such involvement, L-lactate–induced Arc and Zif268
expression was completely abolished in the presence of the
NMDAR antagonist MK801 at 40 μM at both mRNA (Fig. 2A)
and protein levels (Fig. S1 A and H).
L-lactate also increased the phosphorylation of the Extracel-
lular signal-regulated kinase 1/2 (Erk1/2, also known as p44/p42
Mitogen-activated protein kinase, p44/p42 MAPK), involved
in a key signaling cascade mediating the NMDAR-dependent
neuronal plasticity (8–11) (Fig. 2B). Increased Erk1/2 phos-
phorylation occurred within 5 min following L-lactate application
(3.4-fold increase vs. control values, Fig. 2B). Consistent with an
involvement of the Erk1/2 pathway in the action of L-lactate,
stimulation of Arc and Zif268 mRNA levels (Fig. 2C) and protein
levels (Fig. S1 B andH) was blocked by the Erk1/2 kinase inhibitor
U0126 (10 μM). Moreover, phosphorylation of Erk1/2 induced by
L-lactate was selective because it was not reproduced by L-pyruvate
(Fig. S1I). This set of results clearly identifies NMDARs and the
downstream Erk1/2 signaling cascade as main transducers of
L-lactate effects.
NMDAR activity is under the control of complex modulations
(12, 13). In particular, NMDARs possess two main regulatory
binding domains that are referred to as the glutamate and the
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Fig. 1. L-lactate stimulates the expression of the IEGs Arc, c-Fos, and Zif268 in cultured neurons. (A) Concentration–response curve of Arc mRNA expression
following exposure to L-lactate (L-Lac) (n = 9, three independent experiments). (B) Time course of Arc, C-Fos, and Zif268 mRNA induction by 20 mM L-lactate
(n = 9, three independent experiments). (C) IEG mRNA expression 1 h following exposure to various energy substrates applied at 20 mM for L-Lac, D-lactate
(D-Lac), L-pyruvate (L-Pyr), or 10 mM for D-glucose (D-Glu) (n = 12, four independent experiments). (D) Western blots of time-course analysis of IEG protein
expression following exposure to 20 mM L-lactate. (E) Quantification of Western blot bands shown in D (n = 6–5, five independent experiments). (F) IEG
mRNA expression following 1-h exposure to 20 mM L-lactate in the presence or absence of the MCT inhibitor UK5099 (50 μM) (n = 9, three independent
experiments), Data in A–C, E, and F are expressed as percentage of respective control (Ctr or 60-min) values and are mean ± SEM. ***P ≤ 0.001, {P ≤ 0.001, #P ≤
0.01, and *P ≤ 0.05 vs. respective control and ###P ≤ 0.001 vs. respective L-lactate condition with ANOVA followed by Dunnett’s [A (0–10 mM) and B] or
Bonferroni’s (C, E, and F) post hoc tests, or unpaired t test [A (0 and 20 mM)].
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coagonist glycine sites, respectively (13). Efficient opening of
NMDARs usually requires binding of agonists to both regulatory
sites. Using two different approaches, we show that glutamate
binding was necessary for L-lactate to produce its effects. Indeed,
in situ degradation of glutamate, through the addition of gluta-
mate dehydrogenase (GIDH, 6.75 U/mL), as well as application
of the glutamate binding site selective competitive inhibitor
D-(-)-2-amino-5-phosphonopentanoic acid (D-APV) (50 μM),
suppressed the effect of L-lactate on Arc and Zif268 expres-
sion (Fig. 2 D and E). In addition, L-689.560 (10 μM) a se-
lective antagonist at the glycine site, completely antagonized
the stimulatory effect of L-lactate on IEG mRNA expression
(Fig. 2F). A similar effect was obtained using another glycine site
antagonist, 5,7-dichlorokynurenic acid (DCKA, 4 mM) (Fig. S1C).
The inhibitory effects of GIDH, D-APV, L-689.560, and DCKA
were confirmed at the protein levels (Fig. S1 D–G).
In agreement with the activation of NMDARs by L-lactate,
electrophysiological recordings of neurons demonstrate that
NMDAR activation is potentiated by L-lactate. In initial experi-
ments 20 mM L-lactate was used; however, a concentration of
10 mM L-lactate was used in the subsequent electophysiological and
calcium imaging studies. As shown in Fig. 3 A, Left, L-lactate en-
hanced the inward current evoked by application of glutamate
(0.5 μM) and glycine (200 μM) with a peak value of −2.30 ± 0.40 nA
in the presence of L-lactate (n = 8, eight independent experiments)
compared with a peak value of −0.89 ± 0.17 nA (n = 10, 10 in-
dependent experiments) in the control condition. This increase was
completely abolished in the presence of 40 μM MK801 (−0.33 ±
0.07 nA MK801 vs. 0.37 ± 0.04 nA for MK801 + L-lactate; n = 5–6,
five or six independent experiments, P > 0.05 by Student t test). To
further demonstrate that this L-lactate–dependent inward current
potentiation is purely linked to the activation of NMDARs a set of
experiments was performed in the presence of 6,7-dinitroquinoxa-
line-2,3-dione (DNQX, 40 μM), a specific antagonist of AMPA
receptors, and picrotoxin (30 μM), an antagonist of GABAA
receptors. Results clearly showed that the potentiation by L-lactate
of the inward current evoked by glutamate and glycine persisted in
the presence of both inhibitors [peak value of −2.45 ± 0.44 nA in
the presence of L-lactate (n = 8, eight independent experiments)
compared with a peak value of −1.10 ± 0.23 nA (n = 8, eight
independent experiments) in the control condition (Fig. 3 A, Right)].
Opening of ionotropic NMDARs results in calcium influx,
leading to an increase in intracellular calcium ([Ca2+]i) (8). Ac-
cordingly, potentiation of NMDARs by L-lactate, as demon-
strated by electrophysiological recordings, was associated with
NMDAR-dependent [Ca2+]i increase. Fig. 3B shows modulation
in [Ca2+]i monitored by calcium imaging that is induced by
L-lactate (10 mM) following NMDAR activation by glutamate
and glycine, compared with a control condition. The increase was
rapid (peak at 32.27 ± 4.81 s, n = 11, 11 independent experi-
ments) and maintained over time up to 240 s. This effect was
specific for L-lactate (about 2.5-fold increase) and was not
reproduced by D-lactate or L-pyruvate (Fig. 3C). The L-lactate–
induced calcium influx was confirmed to be NMDAR-dependent
because it is prevented in the presence of MK801 (Fig. 3D),
D-APV, and L-689.560 (Fig. S2 A and B). Furthermore, in the
absence of calcium in the extracellular medium L-lactate did not
affect intracellular calcium levels (Fig. S2C).
NADH Mimics the Effects of L-Lactate. Exposure of neurons to
L-lactate modified the intracellular NADH/NAD ratio (Fig. 4A) as
a result of the metabolic processing of L-lactate to L-pyruvate under
normoxic conditions. Consistent with this, L-pyruvate did not affect
the redox state of neurons (Fig. 4A). Moreover, direct application of
NADH (4 mM) resulted in the stimulation of IEG expression at
both mRNA and protein levels as well as Erk1/2 phosphorylation to
an extent similar to that induced by L-lactate (Fig. 4 B–D). Impor-
tantly, the effects of NADH on IEG expression and Erk1/2 phos-
phorylation were antagonized by MK801 (40 μM) (Fig. 4 B–D).
NADH application also resulted in increases in intracellular cal-
cium levels following NMDAR activation by glutamate and
glycine in an MK801–sensitive manner (Fig. 4E). These results
further strengthen the relationship between redox state changes
evoked by L-lactate, NMDAR activation, and IEG expression.
L-Lactate Induces IEG Expression in Vivo. Direct intracortical injec-
tions of L-lactate (four injections of 0.5 μL of 10 mM solution) in
the sensory-motor cortex of anesthetized adult mice also resulted
within 1 h of application in a significant increase in Arc, c-Fos,
and Zif268 mRNA expression (by 61 ± 13%, 60 ± 12%, and 46 ±
8%, respectively) compared with D-lactate (10 mM) injected in
contralateral areas (Fig. 5A). L-pyruvate (10 mM) was similarly
ineffective (Fig. 5B). Of note, IEG expression levels in D-lactate–
and L-pyruvate–injected cortices were not higher than those
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Fig. 2. NMDAR activation and Erk1/2 signaling mediate the effects of
L-lactate. (A) Arc and Zif268 mRNA expression 1 h following exposure to
20 mM L-lactate in the presence or absence of MK801 (40 μM) (n = 9–12, three
or four independent experiments). (B) Representative Western blot and its
quantification for Erk1/2 phosphorylation after a 5-min application of 20 mM
L-lactate (n = 11, four independent experiments). (C–F) Arc and Zif268mRNA
expression following 1-h exposure to 20 mM L-lactate in the presence or
absence of (C) the Erk1/2 inhibitor U0126 (10 μM) (n = 9, three independent
experiments), (D) glutamate dehydrogenase (GIDH, 6.75 U/mL) (n = 6, two
independent experiments), (E) the NMDAR glutamate site antagonist D-APV
(50 μM) (n = 9, three independent experiments), or (F) the NMDAR glycine
site antagonist L-689.560 (L689, 10 μM) (n = 9, three independent experi-
ments). All data are expressed as percentage of respective control (Ctr or
0-min) values as mean ± SEM ***P ≤ 0.001, *P ≤ 0.05 vs. respective Ctr and
###P ≤ 0.001 vs. respective L-lactate condition with ANOVA followed by
Bonferroni’s post hoc test, or unpaired t test (B).
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measured in control, noninjected, more posterior cortical sam-
ples, demonstrating the absence of stimulatory effects on IEG
expression in response to surgery or to D-lactate and L-pyruvate
administration (Fig. S3).
Discussion
Transfer of lactate from astrocytes to neurons is required for
LTM (1), but the underlying molecular mechanisms of this effect
are unknown. Here, we describe a cascade of molecular events
showing that L-lactate stimulates plasticity-related gene expres-
sion in neurons through a modulation of NMDAR activity that is
associated with changes in redox cellular state.
Effects of L-Lactate on Plasticity-Related Gene Expression. Previous
observations reported the ability of L-lactate to stimulate gene
expression in different cell types in culture such as L6 cells,
vasculogenic stem cells, mesenchymal stem cells, or fibroblasts
although the activation of specific transcription factors (14–17).
In the present study we show that L-lactate induces the expres-
sion of key plasticity-related genes, namely, Arc, Zif268, c-Fos,
and BDNF in neuronal cultures. This effect is selective and it
is not reproduced by its nonmetabolized enantiomer D-lactate
or by the energy substrates L-pyruvate and D-glucose applied
at equicaloric concentrations. The dose–response curve on Arc
mRNA expression demonstrates that L-lactate is significantly
effective at a concentration of 2.5 mM. This active concentration
is in the range of estimated extracellular L-lactate concentrations
measured in rodent and human brains [ranging from 0.5 to 5 mM
(18)] and is therefore physiologically relevant.
Consistent with these observations, we show that the stimulatory
effect of L-lactate on Arc, c-Fos, and Zif268 mRNA expression also
occurs in vivo, an effect not reproduced by D-lactate or L-pyruvate.
Involvement of NMDARs. NMDARs are glutamate-gated ion chan-
nels pivotal in the regulation of synaptic plasticity processes as-
sociated with LTM in different learning paradigms (6). They play
a role in synaptogenesis, experience-dependent synaptic remod-
eling, and long-lasting changes in synaptic efficacy such as LTP
(6, 13, 19). NMDARs control the expression of plasticity-related
IEG genes, including Arc, c-Fos, and Zif268. This process is me-
diated by intracellular Ca2+ elevation and subsequent activation of
the Erk1/2 signaling pathways (8, 10, 11).
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Fig. 3. L-lactate potentiates NMDA-receptor inward currents and the ensuing increase in intracellular calcium. (A, Left) Representative electrophysiological
current traces recorded from two different patched neurons, illustrating typical currents triggered by glutamate (0.5 μM) and glycine (200 μM) in the absence
(Ctr, black trace) or the presence of 10 mM L-lactate (L-Lac, red trace). Arrowhead indicates the time of drug application. The bar chart shows quantification of
the difference in amplitude for the two specific currents (n = 8–10, 8–10 independent experiments). (Right) Same as Left but in the presence of 40 μM DNQX
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experiments). (B) Representative average fluctuation curve of Ca2+ fluorescence intensity as measured by calcium imaging with Fluo-4 AM of recorded
neurons following stimulation of NMDARs. Same Ctr and L-Lac conditions as in A, Left. Mean (in dark color) ± SEM (in light color) of 245 and 235 for Ctr and
L-lactate conditions, respectively, recorded neurons from four independent experiments. Arrowhead indicates the time of drug application. (C and D) Average
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condition with ANOVA followed by Bonferroni’s post hoc test (C and D) or unpaired t test (A).
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Experimental in vitro evidence obtained in the present study
reveals that NMDARs and their downstream Erk1/2 signaling
cascade mediate the effects of L-lactate. Thus, (i) L-lactate increases
Erk1/2 phosphorylation and (ii) blockade of NMDAR activity
and/or Erk1/2 phosphorylation by specific inhibitors (MK801 and
U0126, respectively) abolishes L-lactate–induced IEG expression.
L-Lactate Potentiates NMDA Activity. NMDARs are tetrameric pro-
tein complexes composed of a combination of glycine-binding
NR1 subunits and glutamate-binding NR2 subunits and are under
the control of multiple regulatory mechanisms (13). Activation of
NMDARs requires the binding of both the agonist (glutamate)
and a coagonist (glycine or D-serine). In line with this, we observed
that selective inhibition of both binding sites (using L-689.560 and
D-APV, inhibitors of the glycine and glutamate binding sites, re-
spectively) as well as in situ degradation of glutamate by gluta-
mate dehydrogenase impairs the ability of L-lactate to induce IEG
expression. The set of results reported in this study indicates that
the effects of L-lactate do not result from the activation of silent
NMDARs but rather that L-lactate acts as a modulator of already
activated (by glutamate and glycine site coagonists) NMDARs. As
a matter of fact, L-lactate potentiated the NMDAR-dependent
inward current and calcium influx evoked by application of both
glutamate and glycine. Consistent with the effect of L-lactate on
IEG expression, potentiation of NMDARs is selective for
L-lactate; NMDAR-dependent inward current or calcium influx
evoked by application of both glutamate and glycine were not
potentiated by D-glucose (Fig. S4), D-lactate, or L-pyruvate.
Although the experimental evidence presented provides the first
evidence to our knowledge that NMDA receptor-mediated
signaling is positively modulated by L-lactate, the cellular sites of
action (pre/postsynaptic) and the precise molecular determinants
possibly involved in addition to changes in the redox state will re-
quire further investigations.
The Effects of L-Lactate Are Associated with Intracellular Redox
Changes. L-lactate transport into cells through MCTs and fur-
ther metabolism seems an obligatory route to affect cell ener-
getics and functions, although recent evidence suggests that it
could also affect cell responsiveness through its binding to a
specific G-coupled cell surface receptor, GPR81 (20). Consistent
with a transport-mediated effect of L-lactate, IEG expression was
blocked in the presence of the MCT inhibitor UK5099. Once
inside cells, L-lactate is metabolized to L-pyruvate by L-lactate
dehydrogenase, which, using NAD+ as a cofactor, results in the
production of reducing equivalents in the form of NADH.
NADH production is therefore the only specific process that
differentiates L-lactate and L-pyruvate metabolism. As observed
here, L-lactate (but not L-pyruvate) metabolism gives rise to an
intracellular increase of the NADH/NAD ratio, hence modifying
the intracellular neuronal redox state. Redox-sensitive NMDA
regulatory sites are present on the NR1 subunit, which favors
NMDAR activity when in a reduced state and decreases its ac-
tivity when oxidized, as demonstrated in particular with the use
of DTT and 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) (21, 22).
Interestingly, we observed that the stimulatory effect of L-lactate
on IEG expression is prevented in the presence of the oxidizing
agent DTNB (Fig. S5). Further supporting a role of changes in
the redox state of neurons in the modulatory effects of L-lactate
on NMDAR-mediated signaling, we observed stimulatory effects
of NADH on intracellular calcium increases evoked by applica-
tion of both glutamate and glycine, Erk1/2 phosphorylation, and
IEG expression that are markedly inhibited in the presence of
MK801. Overall, results presented in this article point to a redox
state change as the likely mediator of L-lactate.
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Fig. 4. Role of redox state in the effects of L-lactate. (A) NADH/NAD ratio
10 min after application of 20 mM L-lactate or L-pyruvate (n = 12, four in-
dependent experiments). (B–D) Effect of 4 mM NADH (1 h), in the presence
or absence of MK801 (40 μM), on the levels of expression of Arc and Zif268
mRNA (n = 11, four independent experiments) (B) and protein (n = 5, five
independent experiments) (C) and on Erk1/2 phosphorylation (n = 5, five
independent experiments) (D). (E) Average changes of Ca2+ fluorescence
intensity of recorded neurons after 180 s of glutamate (0.5 μM) and glycine
(200 μM) stimulation (Ctr) in the presence of NADH (4 mM) and/or MK801
(40 μM) (n = 109–215, four independent experiments). All data are means ±
SEM. **P ≤ 0.01, ***P ≤ 0.001, vs. respective Ctr (A, B, and E ) and MK801
(C and D) conditions and #P ≤ 0.05, ###P ≤ 0.001 vs. respective NADH con-
dition with ANOVA followed by Bonferroni’s post hoc test.
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Fig. 5. L-lactate stimulates the expression of the IEGs Arc, c-Fos, and Zif268
in vivo. (A and B) IEG mRNA levels following injection of 10 mM L-lactate
[and D-lactate (A) or L-pyruvate (B) in contralateral areas] in sensory-motor
cortex of mice (n = 7–8 mice). Data in A and B are expressed as percentage of
respective control values and are means ± SEM. ***P ≤ 0.001 vs. respective
control with ANOVA followed by Bonferroni’s post hoc test.
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Role of Astrocytes in L-Lactate Production and Neuronal Plasticity.
Astrocytes are emerging as having significant roles in several
homeostatic processes in the brain (23–26). In particular,
astrocytes mediate activity-driven energy delivery to neurons in
the form of L-lactate (25, 27–30). L-lactate can be produced and
released from astrocytes through two neuronally dependent sig-
naling mechanisms. First, through glutamate-evoked glycolysis,
a mechanism also known as the astrocyte–neuron lactate shuttle,
glutamate uptake and the associated increase in intracellular
sodium concentration activate the alpha2 subunit of the Na/K-
ATPase and promote glucose uptake and L-lactate production
(28, 29). A similar neuronal activity-dependent mechanism has
been recently shown for potassium as an activator of astrocytic
glycolysis (31). Another mechanism for L-lactate production is
glycogenolysis (32). In the brain, glycogen is only contained in
astrocytes, where glycogenolysis can be evoked by noradrena-
line and vasoactive intestinal peptide (33). The importance of
L-lactate transfer from astrocytes to neurons to sustain cogni-
tive functions has been shown (1–3). In particular, a major role
of glycogen-derived L-lactate in LTM and LTP in a hippocampal-
based cognitive process such as IA has been demonstrated (1). The
effects of L-lactate are associated with molecular changes required
for memory formation such as Arc induction as well as CREB and
cofilin phosphorylation (1). Hence, the present results showing
that L-lactate (unlike D-glucose and L-pyruvate) induces syn-
aptic plasticity gene expression (i.e., Arc, Zif268, and c-Fos) both
in vitro and in vivo are fully consistent with such observations.
Control of L-lactate metabolism in astrocytes as operated by both
glutamate- and potassium-mediated glycolysis (28, 31) and by
monoamine-mediated glycogenolysis (33) is likely to add another
level of regulation of NMDA activity in general and NMDAR-
mediated synaptic plasticity processes in particular.
It has previously been reported that L-lactate can modulate
neuronal excitability through ATP-dependent mechanisms
involving modulation of KATP channels (ref. 25 and references
therein). Very recently, neuronal activity has been shown to be
also modulated through extracellular actions of L-lactate in-
volving GPR81 or yet-unknown mechanisms (34, 35). Here, we
report that L-lactate stimulates synaptic plasticity-related gene
expression in neurons by a mechanism associated with changes of
the intracellular redox state and the modulation of the NMDAR
activity and its downstream signaling cascade Erk1/2. These
results provide important clues for understanding the molecular
bases underlying the critical role played by astrocyte-derived
L-lactate in the establishment of LTM. More generally, they shed
new light on the role played by L-lactate and by astrocyte–neuron
interactions in the regulation of synaptic plasticity processes, and
hence in learning and memory.
Materials and Methods
Experiments were conducted in accordance with the Swiss Federal Guidelines
for Animal Experimentation and were approved by the Cantonal Veterinary
Office for Animal Experimentation (Vaud, Switzerland). Primary cultures of
cortical neurons (days in vitro 14–21) were treated by direct application of
compounds into the culture medium, or incubation medium, using 50–100×
stock solutions of L-lactate, D-lactate, L-pyruvate, D-glucose, glutamate,
glycine, or NADH. When indicated, specific inhibitors were added 15–30 min
prior to L-lactate, glutamate, glycine, or NADH treatments. A detailed de-
scription of reagents and methodologies (cell culture, quantitative RT-
PCR, Western blot, NAD/NADH assay, electrophysiology, calcium measure-
ment, intracortical administration of compounds, and data analysis) used in
this work can be found in SI Materials and Methods.
ACKNOWLEDGMENTS. We thank Cendrine Barrière Borgioni, Elena Gaspar-
otto, and Valérie Eligert for expert technical assistance; Romain Guiet for
his help for calcium imaging quantification; and Sylvain Lengacher for helpful
discussions. This work was supported by Swiss National Science Foundation
Grants 31003A-130821/1 and 310030B-148169/1 and by the National Centre
of Competence in Research (NCCR) Synapsy and the Biaggi and Panacée
Foundations (P.J.M.).
1. Suzuki A, et al. (2011) Astrocyte-neuron lactate transport is required for long-term
memory formation. Cell 144(5):810–823.
2. Gibbs ME, Anderson DG, Hertz L (2006) Inhibition of glycogenolysis in astrocytes in-
terrupts memory consolidation in young chickens. Glia 54(3):214–222.
3. Newman LA, Korol DL, Gold PE (2011) Lactate produced by glycogenolysis in as-
trocytes regulates memory processing. PLoS ONE 6(12):e28427.
4. Alberini CM (2009) Transcription factors in long-term memory and synaptic plasticity.
Physiol Rev 89(1):121–145.
5. Bramham CR, et al. (2010) The Arc of synaptic memory. Exp Brain Res 200(2):125–140.
6. Lynch MA (2004) Long-term potentiation and memory. Physiol Rev 84(1):87–136.
7. Caroni P, Donato F, Muller D (2012) Structural plasticity upon learning: Regulation
and functions. Nat Rev Neurosci 13(7):478–490.
8. Zhou X, et al. (2009) N-methyl-D-aspartate-stimulated ERK1/2 signaling and the
transcriptional up-regulation of plasticity-related genes are developmentally regu-
lated following in vitro neuronal maturation. J Neurosci Res 87(12):2632–2644.
9. Cammarota M, et al. (2000) Learning-associated activation of nuclear MAPK, CREB
and Elk-1, along with Fos production, in the rat hippocampus after a one-trial
avoidance learning: abolition by NMDA receptor blockade. Brain Res Mol Brain Res
76(1):36–46.
10. Giovannini MG (2006) The role of the extracellular signal-regulated kinase pathway in
memory encoding. Rev Neurosci 17(6):619–634.
11. Sweatt JD (2001) The neuronal MAP kinase cascade: A biochemical signal integration
system subserving synaptic plasticity and memory. J Neurochem 76(1):1–10.
12. Mullasseril P, et al. (2010) A subunit-selective potentiator of NR2C- and NR2D-containing
NMDA receptors. Nat Commun 1:90.
13. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at
central synapses. Sci STKE 2004(255):re16.
14. Hashimoto T, Hussien R, Oommen S, Gohil K, Brooks GA (2007) Lactate sensitive
transcription factor network in L6 cells: Activation of MCT1 and mitochondrial bio-
genesis. FASEB J 21(10):2602–2612.
15. Milovanova TN, et al. (2008) Lactate stimulates vasculogenic stem cells via the thio-
redoxin system and engages an autocrine activation loop involving hypoxia-inducible
factor 1. Mol Cell Biol 28(20):6248–6261.
16. Zieker D, et al. (2008) Lactate modulates gene expression in human mesenchymal
stem cells. Langenbecks Arch Surg 393(3):297–301.
17. Formby B, Stern R (2003) Lactate-sensitive response elements in genes involved in
hyaluronan catabolism. Biochem Biophys Res Commun 305(1):203–208.
18. Zilberter Y, Zilberter T, Bregestovski P (2010) Neuronal activity in vitro and the in vivo
reality: The role of energy homeostasis. Trends Pharmacol Sci 31(9):394–401.
19. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuro-
psychiatric disorders. Nat Rev Neurosci 8(6):413–426.
20. Bergersen LH, Gjedde A (2012) Is lactate a volume transmitter of metabolic states of
the brain? Front Neuroenergetics 4:5.
21. Sullivan JM, et al. (1994) Identification of two cysteine residues that are required for
redox modulation of the NMDA subtype of glutamate receptor. Neuron 13(4):
929–936.
22. Köhr G, Eckardt S, Lüddens H, Monyer H, Seeburg PH (1994) NMDA receptor channels:
Subunit-specific potentiation by reducing agents. Neuron 12(5):1031–1040.
23. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication ele-
ments: The revolution continues. Nat Rev Neurosci 6(8):626–640.
24. Allaman I, Bélanger M, Magistretti PJ (2011) Astrocyte-neuron metabolic relation-
ships: For better and for worse. Trends Neurosci 34(2):76–87.
25. Bélanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: Focus on as-
trocyte-neuron metabolic cooperation. Cell Metab 14(6):724–738.
26. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol
62(6):649–671.
27. Magistretti PJ (2006) Neuron-glia metabolic coupling and plasticity. J Exp Biol
209(Pt 12):2304–2311.
28. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic
glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proc Natl
Acad Sci USA 91(22):10625–10629.
29. Pellerin L, Magistretti PJ (2012) Sweet sixteen for ANLS. J Cereb Blood Flow Metab
32(7):1152–1166.
30. Tsacopoulos M, Magistretti PJ (1996) Metabolic coupling between glia and neurons.
J Neurosci 16(3):877–885.
31. Choi HB, et al. (2012) Metabolic communication between astrocytes and neurons via
bicarbonate-responsive soluble adenylyl cyclase. Neuron 75(6):1094–1104.
32. Dringen R, Gebhardt R, Hamprecht B (1993) Glycogen in astrocytes: Possible function
as lactate supply for neighboring cells. Brain Res 623(2):208–214.
33. Magistretti PJ, Morrison JH (1988) Noradrenaline- and vasoactive intestinal peptide-
containing neuronal systems in neocortex: Functional convergence with contrasting
morphology. Neuroscience 24(2):367–378.
34. Bozzo L, Puyal J, Chatton JY (2013) Lactate modulates the activity of primary cortical
neurons through a receptor-mediated pathway. PLoS ONE 8(8):e71721.
35. Tang F, et al. (2014) Lactate-mediated glia-neuronal signalling in the mammalian
brain. Nat Commun 5:3284.
Yang et al. PNAS | August 19, 2014 | vol. 111 | no. 33 | 12233
N
EU
RO
SC
IE
N
CE
